Korbonits, Márta http://orcid.org/0000-0002-4101-9432
Blair, Joanne C.
Boguslawska, Anna http://orcid.org/0000-0002-1348-3924
Ayuk, John
Davies, Justin H.
Druce, Maralyn R.
Evanson, Jane
Flanagan, Daniel
Glynn, Nigel
Higham, Claire E.
Jacques, Thomas S.
Sinha, Saurabh
Simmons, Ian
Thorp, Nicky
Swords, Francesca M.
Storr, Helen L. http://orcid.org/0000-0002-9963-1931
Spoudeas, Helen A.
Article History
Accepted: 19 December 2023
First Online: 9 February 2024
Change Date: 19 February 2024
Change Type: Update
Change Details: In the version of the article initially published, an earlier, incorrect version of the Supplementary Information was posted. This has now been amended, and the correct Supplementary Information file now accompanies the online article.
Competing interests
: M.K. received grant funding or served on the Advisory Board for Pfizer, Crinetics, Novo Nordisk, Recordati, and ONO Pharmaceuticals and honoraria from Ipsen, Corcept, Sandoz and Novo Nordisk. J.C.B. has received honoraria, funding and travel bursaries from Novo Nordisk and honoraria from Sandoz and Ipsen. J.H.D. has received travel bursaries from Sandoz, Pfizer, and Novo Nordisk and grant funding from Pfizer. T.S.J. is director and shareholder in Repath Ltd. and Neuropath Ltd. and received an honorarium from Bayer. H.L.S. received grant funding from Ipsen and Sandoz and consultancy fees from Novo Nordisk, Pfizer and Springer. H.A.S. has received honoraria from Ferring and Pfizer and grants from Novo Nordisk and Sandoz. The other authors declare no competing interests.
Free to read: This content has been made available to all.